Mullins D, Kirby D, Hwa J, Guzzi M, Rivier J, Parker E
Department of Central Nervous System and Cardiovascular Research, Schering-Plough Research Institute, Kenilworth, New Jersey 07033, USA.
Mol Pharmacol. 2001 Sep;60(3):534-40.
Neuropeptide Y (NPY) binds to a family of G-protein coupled receptors termed Y(1), Y(2), Y(3), Y(4), Y(5), and y(6). The use of various receptor subtype-selective agonists and antagonists has facilitated identification of the receptor subtypes responsible for mediating many of the biological effects of NPY. For example, the potent orexigenic activity of NPY is believed to be mediated by both the Y(1) and Y(5) receptor subtypes. Several selective Y(5) receptor agonists that stimulate food intake in rodents are available, but no selective Y(1) receptor agonist has been reported. We have identified several NPY analogs that bind the NPY Y(1) receptor with high affinity and exhibit full agonist activity, measured as inhibition of forskolin-stimulated cAMP production in cells expressing the cloned NPY Y(1) receptor. [D-Arg(25)]-NPY, [D-His(26)]-NPY, Des-AA(10--17)[Cys(7,21),Pro(34)]-NPY, Des-AA(11--18)[Cys(7,21),D-Lys(9)(Ac)]-NPY, Des-AA(11--18)[Cys(7,21),D-Lys(9)(Ac),Pro(34)]-NPY, Des-AA(11--18)[Cys(7,21),D-Lys(9)(Ac),D-His(26)]-NPY and Des-AA(11--18)[Cys(7,21),D-Lys(9)(Ac),D-His(26), Pro(34)]-NPY bind the NPY Y(1) receptor with K(i) values of 0.9 +/- 0.2, 2.0 +/- 0.3, 0.2 +/- 0.05, 0.7 +/- 0.1, 0.2 +/- 0.01, 2.2 +/- 0.3, and 1.2 +/- 0.3 nM, respectively, and inhibit forskolin-stimulated cAMP production with EC(50) values of 0.2 +/- 0.02, 0.5 +/- 0.04, 0.3 +/- 0.03, 0.5 +/- 0.05, 0.4 +/- 0.16, 5.3 +/- 0.32, and 5.1 +/- 0.97 nM, respectively. These peptides are highly selective for the NPY Y(1) receptor relative to the NPY Y(2), Y(4), and Y(5) receptors. [D-Arg(25)]-NPY, [D-His(26)]-NPY and Des-AA(11--18)[Cys(7,21), D-Lys(9)(Ac),D-His(26),Pro(34)]-NPY stimulate food intake dose-responsively in Long-Evans rats for at least 4 h after intracerebroventricular administration. Although the involvement of Y(1) receptors in several physiological activities, such as vasoconstriction and anxiolysis, remains to be investigated, adequate tools are now available.
神经肽Y(NPY)与一类称为Y(1)、Y(2)、Y(3)、Y(4)、Y(5)和Y(6)的G蛋白偶联受体相结合。使用各种受体亚型选择性激动剂和拮抗剂有助于确定介导NPY许多生物学效应的受体亚型。例如,NPY强大的促食欲活性被认为是由Y(1)和Y(5)受体亚型介导的。有几种能刺激啮齿动物进食的选择性Y(5)受体激动剂,但尚未有选择性Y(1)受体激动剂的报道。我们已鉴定出几种与NPY Y(1)受体高亲和力结合并表现出完全激动剂活性的NPY类似物,其活性通过抑制表达克隆的NPY Y(1)受体的细胞中福斯高林刺激的环磷酸腺苷(cAMP)产生来衡量。[D-精氨酸(25)]-NPY、[D-组氨酸(26)]-NPY、去氨基酸(10-17)[半胱氨酸(7,21),脯氨酸(34)]-NPY、去氨基酸(11-18)[半胱氨酸(7,21),D-赖氨酸(9)(乙酰基)]-NPY、去氨基酸(11-18)[半胱氨酸(7,21),D-赖氨酸(9)(乙酰基),脯氨酸(34)]-NPY、去氨基酸(11-18)[半胱氨酸(7,21),D-赖氨酸(9)(乙酰基),D-组氨酸(26)]-NPY和去氨基酸(11-18)[半胱氨酸(7,21),D-赖氨酸(9)(乙酰基),D-组氨酸(26),脯氨酸(34)]-NPY与NPY Y(1)受体结合,其抑制常数(K(i))值分别为0.9±0.2、2.0±0.3、0.2±0.05、0.7±0.1、0.2±0.01、2.2±0.3和1.2±0.3 nM,并以半数有效浓度(EC(50))值分别为0.2±0.02、0.5±0.04、0.3±0.03、0.5±0.05、0.4±0.16、5.3±0.32和5.1±0.97 nM抑制福斯高林刺激的cAMP产生。相对于NPY Y(2)、Y(4)和Y(5)受体,这些肽对NPY Y(1)受体具有高度选择性。[D-精氨酸(25)]-NPY、[D-组氨酸(26)]-NPY和去氨基酸(11-18)[半胱氨酸(7,21),D-赖氨酸(9)(乙酰基),D-组氨酸(26),脯氨酸(34)]-NPY在脑室内给药后,能在长-伊文斯大鼠中剂量依赖性地刺激进食至少4小时。尽管Y(1)受体在诸如血管收缩和抗焦虑等几种生理活动中的作用仍有待研究,但现在已有足够的工具。